EC Number |
Title |
Organism |
---|
1.3.3.3 | 5-Fluorouracil enhances protoporphyrin IX accumulation and lesion clearance during photodynamic therapy of actinic keratoses A mechanism-based clinical trial |
Homo sapiens |
1.3.3.3 | A case of hereditary coproporphyria with posterior reversible encephalopathy and novel coproporphyrinogen oxidase gene mutation c.863T>G (p.Leu288Trp) |
Homo sapiens |
1.3.3.3 | Acute hepatic porphyrias Identification of 46 hydroxymethylbilane synthase, 11 coproporphyrinogen oxidase, and 20 protoporphyrinogen oxidase novel mutations |
Homo sapiens |
1.3.3.3 | Cystathionine-gamma-lyase (CSE) deficiency increases erythropoiesis and promotes mitochondrial electron transport via the upregulation of coproporphyrinogen III oxidase and consequent stimulation of heme biosynthesis |
Mus musculus |
1.3.3.3 | Fluorouracil enhances photodynamic therapy of squamous cell carcinoma via a p53-independent mechanism that increases protoporphyrin IX levels and tumor cell death |
Homo sapiens |
1.3.3.3 | Fluorouracil enhances photodynamic therapy of squamous cell carcinoma via a p53-independent mechanism that increases protoporphyrin IX levels and tumor cell death |
Mus musculus |
1.3.3.3 | Gametophyte development needs mitochondrial coproporphyrinogen III oxidase function |
Arabidopsis thaliana |
1.3.3.3 | Genetic mapping of a light-dependent lesion mimic mutant reveals the function of coproporphyrinogen III oxidase homolog in soybean |
Glycine max |
1.3.3.3 | Harderoporphyria Case of lifelong photosensitivity associated with compound heterozygous coproporphyrinogen oxidase (CPOX) mutations |
Homo sapiens |
1.3.3.3 | Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase |
Homo sapiens |